Skip to content
★ Sign in to follow
AN

Anat Naschitz

89bio, Inc.
Total declarations
6
Company
1
▲ Purchases (2 ops.)
€12.2M
▼ Sales (2 ops.)
€6.5M

Latest filing published 23 Sept 2020 for 89bio, Inc., €3.3M.

Insider track record

Disclosed buys
2
Disclosed sells
2
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Anat Naschitz: trading record in brief

This profile gathers the share dealings of Anat Naschitz in 89bio, Inc. The record holds 6 filings, for trades running from 11 November 2019 to 21 September 2020.

In open-market terms, that means 2 purchases worth €12.2M on one side and 2 sales worth €6.5M on the other. The net balance comes to €5.6M on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2020 to date brings no purchases and 2 sales.

The newest entry dates from 23 September 2020: an open-market sale of €3.3M, in 89bio, Inc. The clock since the last published purchase (13 November 2019) now reads 2,553 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Anat Naschitz

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▼
    DirectorExecutives89bio, Inc.

    Same trade as the filing by Orbimed Advisors LLC, counted once

    4M USD31SEC
    137,500 shares@ US$28.00100.0% of flowCommon StockSEC:0000947871-20-000749:0
  • ●
    DirectorExecutives89bio, Inc.
    0SEC
    1,277,858 sharesCommon StockSEC:0000899243-19-027225:3
  • ●
    DirectorExecutives89bio, Inc.
    0SEC
    1,277,858 sharesCommon StockSEC:0000899243-19-027225:2
  • ▲
    DirectorExecutives89bio, Inc.

    Same trade as the filing by Orbimed Advisors LLC, counted once

    7M USD36SEC
    418,750 shares@ US$16.0065.0% of flowCommon StockSEC:0000899243-19-027225:0
    Canonical exit: 9 Feb 2020 (T+90)

4 of 2 declarations